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http:WHAT THIS PAPER ADDS
Postoperative stump pain after major lower limb amputation is a significant impediment to the recovery of
amputees. The vast majority of patients require opioid analgesics following surgery, which are associated with
opioid-related side-effects. Continuous perineural catheter infusions of local anesthetic are a safe and effective
method for reducing opioid analgesic medications following lower limb amputations. This adds to existing
literature and is one of the largest studies to date.Objectives: Postoperative stump pain after major lower limb amputation is a significant impediment to the 
recovery of amputees. The vast majority of patients require opioid analgesics following surgery, which are 
associated with opioid-related side-effects. Here, we investigate whether intraoperative placement of a 
peripheral nerve stump catheter followed by continuous infusion of local anesthetic is as effective at pain control 
as current analgesic practices. If beneficial, this procedure could potentially reduce post-amputation opioid 
consumption and opioid-related adverse effects.
Methods: A retrospective chart review was conducted of 198 patients over a 4-year period who had undergone a 
major lower limb amputation for indications related to peripheral vascular disease. Postoperatively, 102 patients 
received a perineural catheter were compared to 96 patients who did not. The primary outcomes of this study 
were the amount of morphine equivalents used in the first 72 hours postoperatively and postoperative pain 
intensity in the first 24 hours.
Results: A total of 198 lower-limb amputations were selected for analyses. Multiple regression analyses indicated 
that perineural catheter use was associated with a lower cumulative postoperative opioid consumption over the 
first 72 hours but not postoperative pain scores at 24 hours. Perineural catheter use led to a 40% reduction in 
opioid use during the first 72 hours postoperatively. Mixed model repeated measures analysis demonstrated that 
this opioid reduction was consistent over time. Other variables related to total opioid use included age, pre-
surgical chronic pain, pre-surgical opioid use, patient-controlled analgesia.
Conclusions: Continuous perineural infusions of local anesthetic are a safe and effective method for reducing 
post-amputation opioid analgesic medications after major lower limp amputation.
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Lower limb amputations lead to significant disability and up
to w80% of patients will suffer from phantom limb and
stump pains.1e4 Stump pain is a significant sequela in the
initial postoperative phase that impedes rehabilitation of
amputees. In addition, the development of chronic pain
following amputation is a long-term complication5 that
greatly impairs quality of life.rresponding author. G. Roche-Nagle, Toronto General Hospital, 200
th Street, Toronto, Ontario M5G 2C4, Canada.
il address: graham.roche-nagle@uhn.ca (G. Roche-Nagle).
//dx.doi.org/10.1016/j.ejvs.2014.07.002Opioids are the most common agents used to manage
postoperative amputation pain. However, opioids are asso-
ciated with substantial adverse effects including delirium,
nausea, and sedation. These adverse effects are particularly
difficult for elderly patients, who make up the largest pop-
ulation of patients undergoing lower limb amputation.3,6
Regional analgesic techniques7,8 provide simple and effec-
tive methods to reduce acute postoperative pain, opioid
use, and their adverse effects.
In this retrospective chart review we evaluate whether
continuous infusion of local anesthetic via a perineural
catheter is as effective as opioids alone, thus offering
potential for reducing post-amputation pain, opioid con-
sumption, and concomitant adverse effects.
METHODS
Approval to conduct the research was obtained from the 
University Health Network research ethics board. The hos-
pital charts of 162 patients undergoing major lower limb 
amputation between January 2009 and June 2013 were 
reviewed. A total of 209 separate amputations were 
reviewed. Nine participants were excluded as extreme 
outliers (4 catheter, 5 non-catheter), using standard outlier 
detection (6 standard deviations or greater).9 An addi-
tional two patients were excluded due to indications un-
related to peripheral vascular disease manifestations (aged 
24 and 37 years, both with congenital abnormalities), leaving 
198 amputation cases for analysis (20 were a second primary 
amputation and 16 were revisions of primary amputations).
The 198 amputations were classified into one of two 
groups. The treatment/catheter group consisted of patients 
who received a continuous perineural stump catheter 
following either a below-knee amputation (BKA) or an 
above-knee amputation (AKA). The second group, the 
comparison group, also underwent BKA or AKA but did not 
receive a perineural stump catheter. As of July 2009, the 
division of vascular surgery gradually began introducing the 
practice of using stump catheters for limb amputation, 
which was driven by a new staff appointment. Patients were 
allocated to group (catheter vs. no catheter) based on the 
attending surgeon availability. Each surgeon was trained in 
the procedure but uptake was variable. The rates of 
perineural catheters were variable over the time period 
studied (2009: 66%; 2010: 34%; 2011: 72%; 2012: 47%; 
2013: 43% of patients receiving catheters in the listed year). 
Patients in both groups received postoperative analgesia 
with opioids that were delivered parenterally by intrave-
nous (IV) patient-controlled analgesia (IV-PCA), non-PCA 
(e.g., oral, transdermal, or nurse-administered IV anal-gesia), 
or a combination of both. Patients were advised by the 
acute pain service (APS) when given IV-PCA devices to 
maintain their pain less than 4/10 (i.e., in the mild rage). At 
our institution, the APS includes an attending anesthesiol-
ogist and several nurse practitioners (NPs) who have 
specialized training in pain management. The APS is involved 
in the care of all patients requiring a PCA device, an epidural, 
or a peripheral nerve/stump catheter following surgery. 
Patients are visited and care issues discussed daily to 
optimize pain control.
The patient records were reviewed for age, gender, level 
of amputation, indication for the operation, placement of a 
perineural catheter, preoperative pain intensity, duration of 
preoperative pain, preoperative pain medication use in the 
24 hours prior to the amputation, and comorbidities, 
specifically diabetes, smoking, and chronic pain (greater than 
6 months in duration). Postoperative analgesic use during 
the first 72 hours postoperatively was documented and 
converted to morphine equivalents (University of Alberta, 
Faculty of Med-icine and Dentistry, Multidisciplinary Pain 
Centre; http://www. uofapain.med.ualberta.ca/en/
ForHealthProfessionals/Opioid ConversionGuide.aspx). 
Postoperative patient-reported painintensity scores during the first 24 hours were recorded on 
an 11-point numeric rating scale (NRS) (0 is “no pain”, 10 
being the “worst pain imaginable”). Finally, duration of the 
peri-neural catheter placement, duration of hospital stay 
post-operatively, time to mobilization, and delirium 
(delirium was assessed by the Confusion Assessment 
Method.10 RNs assess the patients each shift and as 
required), sedation, and nausea were also measured.
Placement of the perineural stump catheter
Five different surgeons placed perineural stump catheters 
that supplied a continuous infusion of ropivacaine (0.2%, 
2e6 mL/hour), bupivicaine (0.25%, 2e5 mL/hour), or lido-
caine (1%, 5e8 mL/hour); 90.20% of catheters delivered 
ropivacaine (0.2%).
Using the described technique of Malawer, et al.,11 at the 
time of amputation, a 20-gauge polyamide catheter (Portex 
4910-16/17) was inserted under direct vision several centi-
meters above the level of transection of either the exposed 
sciatic (AKA) or posterior tibial nerve (BKA), depending on 
the level of amputation. The catheter was then advanced 
cephalad 5e10 cm. The catheter was externalized and 
secured. Typically, a 10-mL bolus was injected into the 
catheter before wound closure to confirm patency of cath-
eter. Continuous infusion of local anesthetic was 
commenced in the recovery room. We limited the infusion 
volume to 2 mL/hour in the BKAs due to the small 
compartment space.
Statistical analysis
Standard methods were used to assess the appropriateness 
of statistical techniques and to investigate outliers including 
standardized scores, probability of Mahalanobis distance 
and/or Cooks’s distance as appropriate.9 Of the 165 par-
ticipants, nine were excluded as extreme outliers (4 cath-
eter, 5 non-catheter). Two participants were excluded due 
to indications unrelated to peripheral vascular disease, 
leaving a total of 198 amputations for analysis. Participant 
demographics were compared between catheter and non-
catheter groups using t tests, Fisher exact tests, and chi-
square analyses as appropriate. A Bonferroni correction 
was applied to the Type I error rate when comparing pre-
surgical variables, setting alpha at 0.01.
Regression analyses
Independent exposure variables were classified into five 
categories: (a) demographic variables (gender, age), (b) 
preoperative comorbidities (diabetes, chronic pain and 
smoking status), (c) pre-surgery measures (pre-surgery pain 
level, pre-surgery opioids), (d) PCA status, and (e) perineural 
catheter status. The analysis performed in this study is a 
three-step series of multiple linear regressions, which are 
built up to the final linear regression model. The first linear 
regression involved running each variable (age, sex, etc.) as 
its own linear regression in relation to the dependent var-
iable of total opioid use (unadjusted beta). The unadjusted 
beta represents the ability of each individual variable to 
predict total morphine use. Positive values are associated
Table 1. Demographic and preoperative medical variables.
Catheter 
(n ¼ 102)
Non catheter
(n ¼ 96)
Mean age in years (SD) 69.9 (11.78) 66.29 (11.85)
Gender
Male n (%) 65 (48.9) 68 (51.1) 
Mean preop 24 hour opioid 20.01 (29.99) 15.40 (17.56) 
in mg (SD)
Patient-controlled analgesia, 75 (73.5) 74 (77.1) 
n (%)
Diabetes status, n (%) 67 (65.7) 75 (78.1)
Smoking status n (%) 49 (48) 57 (59.4)
History of chronic pain n (%) 32 (31.4) 34 (35.4)
Mean preoperative pain score 5.14 (3.44) 4.83 (3.24)
(SD)
Note. There was no significant difference between the groups on 
these variables (Bonferroni correction applied for multiple 
comparisons).with increased opioid use and negative values are associ-
ated with decreased opioid use after amputation. Second, a 
subsequent multivariate linear regression was conducted for 
each group (demographics, comorbidities, etc.) using 
significant variables from within its group that were ob-
tained from the first linear regression (group adjusted beta), 
postoperative opioid use was the dependent variable. The 
group-adjusted beta score represents the score of each in-
dividual predictor adjusted for the other predictors within its 
group in relation to postoperative opioid use (de-mographic, 
pre-surgery scores, PCA, comorbidity). Finally, a third 
multivariate linear regression was conducted. The final 
model took all variables that were significant predictors of 
total opioid use in their respective groups from the second/
group-adjusted linear regression and were used to build the 
final multivariate linear regression (fully adjusted beta). For 
each category of exposure variable listed above, separate 
multivariate regression analyses were conducted to ascer-
tain the variables that showed a significant relationship with 
the dependent variable (postoperative opioid consump-
tion). A complete multivariable model was then created 
using all variables found to have a significant relationship 
with the dependent variable in the previous models, as well 
as the main variable of interest (perineural catheter status). 
All analyses were conducted with SPSS (IBM, New York, USA) 
version 10.05, using a significance level of 0.05.
Mixed-model repeated measures ANOVA. A mixed-model 
repeated measures ANOVA was conducted on morphine 
consumption using time as the within-subjects factor, cath-
eter status as the between-subjects factor and the time by 
catheter status interaction term to assess whether the effect 
of catheter use on morphine consumption varied by time. 
Repeated measures analysis is especially susceptible to the 
effects of outliers. Accordingly analyses were run on the 
original post-surgical measures of morphine use excluding 
the extreme outliers (n ¼ 198), and also on a (logþ1) 
transformation of the morphine variables on all participants 
used, to acquire a more normal distribution (n ¼ 205).
RESULTS
Descriptive statistics
A total of 162 individual patients underwent 198 lower limb 
amputations (20 were second primary contralateral ampu-
tations and 16 were revisions of previous ipsilateral am-
putations) for peripheral vascular disease (67% male, 33%
female), with an average age of 68 years. Demographics, 
comorbidities, and perioperative variables are presented in 
Table 1. There were no significant differences between the 
catheter and non-catheter groups in gender, age, previous 
chronic pain, smoking status, diabetes status, preoperative 
pain scores, preoperative 24-hour opioid, or above knee vs. 
below knee assignment in surgery (all p > .05).
Postoperative opioid use
The use of analgesic medications was converted to 
morphine equivalents. Multivariable regression analysis wasused to determine which variables were related to post-
operative opioid use. Stump catheter use was associated 
with a significantly lower total postoperative opioid use 
(catheter 81.23  90.77 vs. non-catheter 134.51  145.49, p 
¼ .03).
In the initial multivariable regression models (see 
Methods), age, and perineural catheter use were associ-ated 
with significantly less total opioid use in the first 72 hours 
postoperatively. While chronic pain, preoperative opioid 
use, and PCA status were significantly associated with 
increased total opioid use after amputation (Table 2). In the 
full multivariable model, all these variables remained 
significant. With the above-listed variables held constant, 
perineural catheter use remained a significant predictor of 
lower total post-surgical opioid use (p ¼ .004). There was a 
decrease in total opioid with increased age, while 
preoperative opioid use, PCA use, and preoperative chronic 
pain were all associated with an increase in total opioid use.
Mixed-model repeated measures ANOVA
Table 3 summarizes the average opioid use at each interval 
by catheter status (n ¼ 198). As seen in the average total 72-
hour opioid use, patients given a perineural catheter used, 
on average, 40% less opioid than those not receiving a 
perineural catheter (T ¼ 3.11, p ¼ .03). Total opioid use was 
also examined during three post-surgery time frames: 0e24 
hours, 24e48 hours, and 48e72 hours. The time by cath-
eter status interaction was non-significant (p > .22), indi-
cating that the opioid sparing effect seen with perineural 
catheter use does not differ significantly as a function of the 
time frame sampled, while the overall between-subject ef-
fect of perineural catheter use was significant (p ¼ .03).
Use of non-opioid analgesics
There was no difference between the catheter and non-
catheter group in the relative use of gabapentin (catheter 
40 of 102, 39.22% vs. non-catheter 35 of 96, 36.46%, 
p ¼ .77).
Table 2. Multivariate linear regressions with adjusted and unadjusted beta for the association between demographic variables and total post-surgical opioid use.
Cases (n ¼ 102) Comparison group
(n ¼ 96)
Single variable unadjusted
beta (95% CI)
Within group adjusted
beta (95% CI)a
Fully adjusted beta (95% CI)b p-values for fully
adjusted beta results
Mean age (SD) 69.9 (11.78) 66.29 (11.85) 4.59 (5.89 to 3.28) 4.62 (5.92 to 3.33) 3.46 (4.70 to 2.22) <.0001
Sex n (%)
Male 65 (48.9) 68 (51.1)
Female 37 (56.9) 28 (43.1) 25.48 (11.16 to 62.13) 29.30 (3.52 to 62.14)
Catheter status n (%)
Catheter 102 (100) d 53.28 (87.05 to 19.50) d 42.88 (71.76 to 14.01) .004
No catheter d 96 (100)
History of chronic pain n (%)
Yes 32 (31.4) 34 (35.4) 75.67 (40.58 to 110.77) 72.75 (36.94 to 108.57) 50.16 (18.45 to 81.86) .002
No 70 (68.6) 62 (64.6)
Mean preop 24-hour opioid (SD) 20.01 (29.99) 15.40 (17.56) 1.90 (1.25 to 2.55) 1.51 (0.70 to 2.23) 1.17 (0.54 to 1.80) <.0001
Patient-controlled analgesia n (%)
Yes 75 (73.5) 74 (77.1) 45.40 (5.84 to 84.95) d 35.68 (2.34 to 69.03) .036
No 27 (26.5) 22 (22.9)
Diabetes status n (%)
Yes 67 (65.7) 75 (78.1) 24.73 (63 to 13.5) 26.69 (63.39 to 10.02)
No 35 (28.3) 21 (21.9)
Smoking status n (%)
Yes 49 (48) 57 (59.4) 28.31 (6.13 to 62.75) 15.11 (18.78 to 48.99)
No 53 (52) 39 (40.6)
Mean preoperative pain score (SD) 5.14 (3.44) 4.83 (3.24) 7.83 (1.59 to 14.06) 5.06 (0.98 to 11.10)
a Adjusted for group variables only. While unadjusted beta represents each individual measures ability to predict total opioid use, this score represents the score of each individual predictor
adjusted for the other predictors in its group (demographic, pre-surgery scores, PCA, comorbidity).
b Adjusted for all variables that were significant predictors of total morphine use in their respective groups (demographics, pre-surgery scores, PCA and comorbidity). Variable(s) significant in
the final model are age, catheter status, pre-surgical opioid use, PCA status, and pre-surgical chronic pain.
Table 3. Mean (SD) opioid use in milligrams during 0e24, 24e48,
and 48e72 hour post-surgery time frames by treatment group.
Time frame Perineural catheter Non-catheter
0e24 hours 30.28 (33.17) 50.53 (55.88)
24e48 hours 26.92 (34.84) 46.42 (60.30)
48e72 hours 24.85 (36.30) 36.95 (44.44)
72-hour total 81.23 (90.77) 134.51 (145.49)*
*p ¼ .03.Postoperative pain
Postoperatively, multiple regression analysis revealed no
difference between the catheter and non-catheter groups
in total pain after amputation. In both groups the average
24-hour postoperative pain intensity was low (catheter
3.02  2.12 vs. non-catheter 3.38  2.12).
Above-knee versus below-knee amputations
Surgeries in this study were a roughly equal mix of AKA and
BKA cases (109 AKA vs. 89 BKA). There was no significant
difference in the amount of opioid used between AKA and
BKA groupings postoperatively (AKA 104.92  110.86 vs.
BKA 109.68  137.14; p ¼ .79). Pain levels were signifi-
cantly lower for AKAs than BKAs (AKA 2.81  2.13 vs. BKA
3.66  2.03 p ¼ .046, CI 6.0 to 0.14).
Mobilization after amputation
The number of days to sit up in bed (catheter 1.86  1.21
days vs. non-catheter 1.61  0.85 days, p ¼ .21) or to
mobilize out of bed within 3 days after amputation (cath-
eter 27.28% [18 of 66] vs. non-catheter 20.00% [9 of 45],
p ¼ .51) were not different between the catheter and non-
catheter groups.
Adverse events
Delirium. The one-sided Fisher exact test was used to 
examine the hypothesis that lower opioid use in the cath-
eter group would be associated with lower levels of post-
surgical delirium. The results revealed a trend for delirium 
levels to be lower in the catheter group (n ¼ 207; p ¼ .054).
Sedation and nausea. The occurrence of sedation (catheter 
3 patients vs. non-catheter 5 patients) and nausea (catheter 
1 vs. non-catheter 1) were very low and precluded statis-
tical analyses.
Catheter failure. Perineural catheters remained in place for 
an average of 3.89  1.34 days (range 1e7). Nine catheters 
failed, five became blocked, two were disconnected by the 
patient, one line became kinked, and one was incompletely 
inserted in the operating room. Although failure occurred in 
8.8% (9 of 102) of the catheters there was no difference in 
the average time to discharge from the hospital following 
amputation (catheter 17.00  13.26 days vs. non-catheter 
17.88  14.06 days; p ¼ .670). The yearly failure rate of 
catheters was low and the rates decreased from year to 
year (2009: 18.75% [3 of 16]; 2010: 12.5% [2 of 16]; 2011: 
9.1% [3 of 33]; 2012: 4.0% [1 of 25]; 2013: 0% (0 of 12).Deaths. There were eight in-hospital deaths in this sample 
(catheter 5; non-catheter 3). Chi-square analysis revealed 
no significant differences in the number of deaths based on 
catheter status (p ¼ .33).DISCUSSION
This retrospective chart review of 198 consecutive ampu-
tations showed that continuous infusion of local anesthetic
via perineural catheters is an effective tool to reduce opioid
analgesic consumption following lower limb amputation. In
the present study, although postoperative pain was well
managed in both groups a significant between-group dif-
ference in pain scores did not emerge. The use of perineural
catheters provided equivalent postoperative pain control
relative to the comparison group with significantly less
opioid usage.
Previously, it has been reported that perineural analgesia
at the surgical site is a safe and effective method that leads
to a significant reduction in postoperative opioid con-
sumption for patients undergoing various surgeries.3,12e17
Several previous studies have examined the use of peri-
neural catheters to control postoperative amputation pain
but have produced varied results with small sample
sizes.3,14,16,18e21
This current study is the largest evaluation of perineural
infusion catheters following lower limb amputations. Our
results indicate that the use of perineural infusion catheters
effectively reduces post-amputation consumption of opioid
analgesics with comparable pain scores up to 24 hours. The
ability to reduce opioid consumption after amputation but
to still maintain adequate pain control is particularly
important for patients of advanced age who may be more
susceptible to the side-effects of opioids.3 Although we
investigated whether there was a decrease in delirium
following lower limb amputation with perineural catheter
use, this study was underpowered to have found it. Peri-
neural catheter use was found to be safe and failure rates
were low without an increase in adverse events, which is in
line with previous studies.3,14,16,18e20
In addition to the side effects of opioid analgesics, post-
amputation pains are a significant problem for patients
recovering from lower limb amputations. We were unable
to find any differences in the patient-reported pain scores
between the comparison group and the catheter group.
Patients in both groups had their pain very well controlled
while in hospital.20 The low levels of postoperative pain in
each group support this conclusion. In studies where pain is
well controlled, the level of pain medications required by
patients may be a better means to assess the efficacy of
analgesic regimens such as perineural catheters. Impor-
tantly, we noted no differences between AKA and BKA
groups in their levels of postoperative opioid use.
There are several limitations to this study. First, given the
retrospective nature of the data collected, adequate stan-
dardization of postoperative care cannot be assured. Sec-
ond, there may be a surgeon bias to provide patients with
higher morbidity a perineural catheter. Third, due to the
variability in the data and small-to-moderate sample size,
confidence intervals in the analyses were large. Finally, pain
data were not available beyond 24 hours after patients
were discharged from the APS.
In this report we did not address whether perineural
stump catheters are able to reduce phantom limb pains
after amputation. Previous reports after lower limb ampu-
tation have suggested that perineural catheters may be
effective in reducing phantom limb pains.3,14,19 However,
phantom limb pain is a complex phenomenon that likely
develops due to a combination of pre-amputation pain1,22e
24 as well as the transection of nerves at the time of surgery,
and ectopic activity from the transected fibers after sur-
gery.25 Based on the results presented here a large ran-
domized, double-blinded study with clear endpoints should
be implemented. A prospective study would enable inves-
tigation into the possibility of effectively lowering rates of
stump and phantom limb pains.3,14,25e27
In conclusion, continuous perineural catheter infusions of
local anesthetic are a safe and effective method for
reducing opioid analgesic medications following lower limb
amputations.
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